Do people with dementia and mild cognitive impairments experience stigma? A cross-cultural investigation between Italy, Poland and the UK.

Aging & Mental Health
Katarzyna Małgorzata LionJoanna Rymaszewska

Abstract

Objectives: Until now little research has been done to answer the question of whether people with dementia experience stigma. No previous studies investigated possible differences between countries and cultures. Therefore, the aims of this study were to compare the experience of stigma (with social isolation, social rejection and internalised shame as components) among people with dementia and mild cognitive impairment (MCI) (n = 180) in Italy (n = 79), Poland (n = 47) and the United Kingdom (UK) (n = 54); and to investigate possible relationships with demographical and clinical outcomes.Methods: A one group multinational cross-sectional design was used. Stigma was measured with the Stigma Impact Scale (SIS), quality of life aspects with Dementia Quality of Life scale (DQOL) and Quality of Life Alzheimer's Disease scale (QOL-AD), social support with Duke Social Support Index (DSSI), cognitive functioning with Global Deterioration Scale (GDS).Results: The level of stigmatisation (SIS) among study participants varied from 2 to 65 (median = 33.5; Q1 = 27; Q3 = 41). People with dementia in the UK experienced a higher level of stigmatisation than people in Italy and Poland. The experienced stigmatisation negatively correlated with s...Continue Reading

References

Apr 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·L K GeorgeN Fowler
Feb 1, 1988·Biological Psychiatry·G S AlexopoulosC A Shamoian
Sep 1, 1982·The American Journal of Psychiatry·B ReisbergT Crook
May 22, 2002·Psychosomatic Medicine·Rebecca G LogsdonLinda Teri
Jul 25, 2003·Social Science & Medicine·Linda Clare
Oct 20, 2004·The American Psychologist·Patrick Corrigan
Feb 14, 2006·Lancet·Bruce G Link, Jo C Phelan
Dec 13, 2007·Croatian Medical Journal·Norman Sartorius
Feb 26, 2008·Aging & Mental Health·E Moniz-CookUNKNOWN INTERDEM group
Jan 19, 2010·Research in Gerontological Nursing·Linda GarandMary Amanda Dew
Apr 25, 2012·Social Psychiatry and Psychiatric Epidemiology·Alina BeldieJohannes Wancata
Feb 15, 2013·The Gerontologist·Hannah Zeilig
Dec 18, 2013·Dementia·Sandy C BurgenerCarolyn Hahn-Swanson
May 23, 2014·The Nursing Clinics of North America·Rebecca J RileyKathleen C Buckwalter
Oct 19, 2014·Dementia·Kate Swaffer
Nov 29, 2014·The International Journal of Social Psychiatry·Gabriele Cipriani, Gemma Borin
Mar 15, 2015·Aging & Mental Health·D GoveN Small
May 6, 2015·Epidemiology and Psychiatric Sciences·M SemrauG Thornicroft
Sep 19, 2015·The British Journal of Psychiatry : the Journal of Mental Science·Antonio LasalviaUNKNOWN ASPEN/INDIGO Study Group
Aug 16, 2017·Journal of Health Psychology·Rosalie Ashworth

❮ Previous
Next ❯

Citations

Jul 17, 2019·International Psychogeriatrics·Perla WernerChariklia Tziraki
Nov 14, 2020·Journal of Alzheimer's Disease : JAD·Magdalena Rewerska-Juśko, Konrad Rejdak
Aug 10, 2021·Journal of Clinical and Experimental Neuropsychology·Syarifah Maisarah Syed AlwiNormah Che Din

❮ Previous
Next ❯

Software Mentioned

DQOL
MEETINGDEM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved